Status:

COMPLETED

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

Lead Sponsor:

Kevin Hill

Collaborating Sponsors:

National Center for Advancing Translational Sciences (NCATS)

Conditions:

Congenital Heart Disease in Children

Inflammatory Response

Eligibility:

All Genders

Up to 12 years

Phase:

PHASE3

Brief Summary

This study's objective is to determine the pharmacokinetics (PK)/pharmacodynamics (PD), safety and efficacy of methylprednisolone in infants undergoing heart surgery with cardiopulmonary bypass. This ...

Detailed Description

Overview: Congenital heart diseases (CHD) are the most common birth defects, occurring in nearly 1% of live births. Every year, an estimated 40,000 infants born in the U.S. suffer from CHD. Despite a...

Eligibility Criteria

Inclusion

  • Age \< 1 year at the time of surgery
  • Undergoing heart surgery with CPB as part of standard clinical care
  • Availability and willingness of the parent/legally authorized representative to provide written informed consent

Exclusion

  • \< 37 weeks adjusted gestational age at time of surgery
  • Any oral or intravenous steroid treatment within two days of surgery
  • Any patient receiving any of the following medications within 2 days of surgery:
  • Amphotericin B, aminoglutethimide, anticholinesterases, warfarin, P450 3A4 inducers including (but not limited to) carbamazepine, phenobarbital, phenytoin, rifampin, bosentan and nafcillin or P450 3A4 inhibitors including (but not limited to) clarithromycin, voriconazole, itraconazole, ketoconazole, ciprofloxacin, diltiazem, fluconazole, erythromycin and verapamil.
  • Infection contraindicating steroid use
  • Preoperative mechanical circulatory support or active resuscitation at the time of randomization
  • Emergent surgery precluding steroid administration 8-12 hours before surgery

Key Trial Info

Start Date :

October 18 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2022

Estimated Enrollment :

1263 Patients enrolled

Trial Details

Trial ID

NCT03229538

Start Date

October 18 2017

End Date

March 31 2022

Last Update

January 5 2026

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Children's Hospital of Los Angeles

Los Angeles, California, United States, 90027

2

University of Colorado, Denver

Aurora, Colorado, United States, 80045

3

University of Florida Health - Shands Hospital

Gainesville, Florida, United States, 32608

4

Ann & Robert Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611-2605